Predictors of intractable childhood epilepsy

Berna Seker Yilmaz1, Cetin Okuyaz, Mustafa Komur

  • 1Department of Pediatrics, University of Mersin, Mersin, Turkey. berna_seker@yahoo.co.uk

Pediatric Neurology
|January 8, 2013
PubMed

Insights

Early prediction of medically intractable childhood epilepsy is possible. Key factors include prior status epilepticus, abnormal EEG, and multiple daily seizures, aiding treatment strategies.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Background:

  • Childhood epilepsy affects many children, with a subset developing medically intractable forms.
  • Identifying early predictors for intractable epilepsy is crucial for timely intervention.

Purpose of the Study:

  • To identify early predictive factors for medically intractable childhood epilepsy.
  • To guide therapeutic strategies and improve seizure control in affected children.

Main Methods:

  • Retrospective investigation of a pediatric epilepsy cohort from Mersin.
  • Classification into drug-responsive and intractable epilepsy groups based on treatment response (>18 months).
  • Univariate and logistic regression analyses to determine predictive factors.

Main Results:

  • Significant univariate associations found with age of onset, seizure frequency, etiology, seizure types, history of seizures (status epilepticus, febrile, neonatal), developmental delays, and EEG/MRI findings.
  • Independent predictors identified: history of status epilepticus, abnormal electroencephalogram (EEG), and multiple seizures per day.
  • Intractable epilepsy defined as persistent seizures despite >18 months of therapy with ≥2 antiepileptic drugs.

Conclusions:

  • History of status epilepticus, abnormal EEG, and multiple daily seizures are independent predictors of medically intractable childhood epilepsy.
  • Monitoring these factors allows for early prediction of intractable epilepsy.
  • Early prediction facilitates the design of alternative therapies for better seizure control and quality of life.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...